Divya Sood, MD
Dr. Divya Sood is a surgical oncologist at the Knight Cancer Institute and OHSU Health in Portland, Oregon. She specializes in treating patients with abdominal cancers, including malignant peritoneal mesothelioma, and is particularly skilled in the use of the complex procedure known as cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. This procedure begins with removing all visible tumor material, and then applying a solution of concentrated heated chemotherapy directly into the surgical site. The procedure is only available at a few facilities throughout the United States.[1]
Dr. Sood manages her patients’ complex malignancies with a strong focus on what is best for the patient. She works as part of the Knight Cancer Institute multidisciplinary gastrointestinal cancer team to ensure that treatment decisions consider all aspects of quality of life.
Education and Career
Dr. Sood completed her undergraduate education at Cornell University, where she graduated with a bachelor of science degree. She earned her medical degree at the University of Minnesota Medical School, then completed her internship and residency in General Surgery at the University of California, San Diego. She pursued a fellowship in Complex General Surgical Oncology at the University of Chicago and another in Cancer Therapeutics Research at the Moores Cancer Center at the University of California San Diego.[1]
In addition to seeing patients at the Knight Cancer Institute and OHSU Health, Dr. Sood is an assistant professor of surgery in the Division of Surgical Oncology at the OHSU School of Medicine.
Professional Memberships and Associations
- Society of Surgical Oncology
- Association for Academic Surgery
- Society of Asian Academic Surgeons
- American Association for Cancer Research
- American College of Surgeons
- Association of Women Surgeons
Research
Dr. Sood is an active researcher. Her interests lie in investigating molecular and cellular biomarkers to improve understanding of who will benefit the most from different types of treatments. She is interested in designing more inclusive clinical trials to ensure that all patients have better access to advanced technologies and therapies.
She has authored or co-authored numerous articles that have appeared in prestigious medical journals. Her most recently published articles include:[1]
ASO Visual Abstract, Annals of Surgical Oncology Jan 1, 2023. Cecilia T. Ong Ankit Dhiman Anthony Smith Angela Jose Pujitha Kallakuri Jennifer Belanski Divya Sood Hunter D.D. Witmer Ryan B. Morgan Kiran K. Turaga Oliver S. Eng
Extended postoperative thromboprophylaxis after pancreatic resection for pancreatic cancer is associated with decreased risk of venous thromboembolism in the minimally invasive approach, Journal of Surgical Oncology Mar 2023. Divya Sood Kristine Kuchta Pierce Paterakos Jason L. Schwarz Aram Rojas Sung H. Choi Charles C. Vining Mark S. Talamonti Melissa E. Hogg
Insurance Authorization Barriers in Patients Undergoing Cytoreductive Surgery and HIPEC, Annals of Surgical Oncology Jan 2023. Cecilia T. Ong Ankit Dhiman Anthony Smith Angela Jose Pujitha Kallakuri Jennifer Belanski Divya Sood Hunter D.D. Witmer Ryan B. Morgan Kiran K. Turaga Oliver S. Eng
Mutational profiles and prognostic impact in colorectal and high-grade appendiceal adenocarcinoma with peritoneal metastases, Journal of Surgical Oncology. Apr 2023. Ryan B. Morgan Ankit Dhiman Divya Sood Cecilia T. Ong Xiaoyang Wu Ardaman Shergill Blase Polite Kiran K. Turaga Oliver S. Eng
Palliative Care and Characterization of Symptoms in Patients Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy, Journal of Surgical Research Mar 2023. Abigail P. Sneider Ankit Dhiman Divya Sood Cecilia Ong Sandy Tun Monica Malec Stacie Levine Kiran K. Turaga Oliver S. Eng
Role of Tumor-informed Personalized Circulating Tumor DNA Assay in Informing Recurrence in Patients with Peritoneal Metastases from Colorectal and High-grade Appendix Cancer Undergoing Curative Intent Surgery, Annals of Surgery Dec 1, 2023. Ankit Dhiman Vishesh Kothary Hunter D.D. Witmer Celyn Bregio Divya Sood Cecilia T. Ong Blase Polite Oliver S. Eng Ardaman Shergill Kiran K. Turaga
ASO Visual Abstract, Annals of Surgical Oncology Dec 1, 2022. Ankit Dhiman Charles C. Vining Hunter D.D. Witmer Divya Sood Ardaman Shergill Hedy Kindler Kevin K. Roggin Mitchell C. Posner Osmanuddin S. Ahmed Stanley Liauw Sean Pitroda Chih Yi Liao Theodore Karrison Ralph Weichselbaum Blasé Polite Oliver S. Eng Daniel V.T. Catenacci Kiran K. Turaga
Bile leak incidence, risk factors and associated outcomes in patients undergoing hepatectomy, Surgical Endoscopy, and Other Interventional Techniques Aug 2022. Charles C. Vining Kristine Kuchta Amr I. Al Abbas Phillip J. Hsu Pierce Paterakos Darryl Schuitevoerder Divya Sood Kevin K. Roggin Mark S. Talamonti Melissa E. Hogg
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels, Annals of Surgical Oncology Jul 2022. Ankit Dhiman Charles C. Vining Hunter D.D. Witmer Divya Sood Ardaman Shergill Hedy Kindler Kevin K. Roggin Mitchell C. Posner Osmanuddin S. Ahmed Stanley Liauw Sean Pitroda Chih Yi Liao Theodore Karrison Ralph Weichselbaum Blase Polite Oliver S. Eng Daniel V.T. Catenacci Kiran K. Turaga
